Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
Kilmurry MR, Heathcote EJ, Cauch-Dudek K, O'Rourke K, Bailey RJ, Blendis LM, Ghent CN, Minuk GY, Pappas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Worobetz LJ.
Kilmurry MR, et al. Among authors: heathcote ej.
Hepatology. 1996 May;23(5):1148-53. doi: 10.1002/hep.510230532.
Hepatology. 1996.
PMID: 8621147
Clinical Trial.